Seegene USA Inc. has received FDA Emergency Use Authorization for the Allplex HSV1-1&2/VZV2/MPXV3 Assay, a multiplex ...

Countable Labs announces Ancora assays for molecular testing of hematologic malignancy, marking the company's entry into clinical markets.

Seqlo by DSS Imagetech, a market leader in advanced molecular diagnostics,bridges a critical gap in the food industry by empowering food brands to step up theircredibility and compliance and earn ...

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...

Detailed price information for Co-Diagnostics Inc (CODX-Q) from The Globe and Mail including charting and trades.

Macrolide antibiotics such as azithromycin have long been the cornerstone of treatment for Mycoplasma pneumoniae, a leading ...

Get latest articles and stories on Business at LatestLY. New Delhi [India], September 29: As food brands and restaurants ...

New research shows a blood test can detect returning breast cancer months to years before scans or symptoms appear.

The molecular diagnostics market size is valued at USD 17.6 billion in 2025 and is projected to reach USD 36.2 billion by the end of 2035, with a compound annual growth rate (CAGR) of 7.4% during the ...

Co-Diagnostics, Inc. announced that the companies are collaborating to evaluate the potential use of ReadyGo Diagnostics Ltd.'s sample-preparation technology with the Co-Dx PCR platform for ...